Taft Stettinius & Hollister advised Further on the deal. Willkie Farr & Gallagher advised HealthEquity. HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity”), the nation’s largest independent health savings...
HealthEquity’s $455 Million Acquisition of Further
StemoniX’s Merger with Cancer Genetics
Taft Stettinius & Hollister LLP advised StemoniX, Inc on the deal. Cancer Genetics, Inc. (the “Company” or “CGI”) (Nasdaq: CGIX), an emerging leader in novel drug...